Meloxicam Kleva 7,5 Mg

Meloxicam, the active ingredient in Meloxicam Kleva 7.5 Mg is a NSAID for oral use. It works by reducing hormones that cause pain, fever, and inflammation in the body. It treats osteoarthritis, rheumatoid arthritis and acute pain in adults. Meloxicam is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints).

Meloxicam is also used to relieve the pain, tenderness, swelling, and stiffness caused by juvenile rheumatoid arthritis (a type of arthritis that affects children) in children 2 years of age and older.

GNH USA supplies Meloxicam Kleva 7.5 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is a non‑steroidal anti‑inflammatory drug used to manage inflammatory joint conditions and acute pain.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: decreases inflammation and slows disease progression. - Acute pain: provides short‑term relief of moderate pain.

Adverse reactions may occur with meloxicam use.

Common Side Effects: - Gastro‑intestinal discomfort or dyspepsia. - Headache. - Dizziness. - Mild skin rash. - Elevated blood pressure. - Peripheral edema.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding. - Severe liver injury (hepatotoxicity). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute renal impairment. - Cardiovascular thrombotic events (myocardial infarction, stroke). - Anaphylactic or severe hypersensitivity reactions.

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Renal function: assess baseline and monitor in patients with renal impairment. - Hepatic function: evaluate liver enzymes prior to initiation and during therapy. - Cardiovascular risk: use cautiously in patients with a history of heart disease or stroke. - Gastro‑intestinal safety: avoid in patients with active peptic ulcer disease or a history of serious GI bleeding. - Pregnancy and lactation: contraindicated unless benefits outweigh potential risks; consult obstetric guidance. - Store at room temperature below 25°C: keep in the original container, protect from moisture and light.

Meloxicam may interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: elevated lithium serum concentrations. - Methotrexate: enhanced toxicity, especially at high doses. - Cyclosporine: heightened nephrotoxic potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: risk of electrolyte imbalance and reduced renal clearance. - SSRIs or SNRIs: additive bleeding risk, monitor for signs of hemorrhage.